BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 12659975)

  • 1. Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.
    Chang KP; Reed SG; McGwire BS; Soong L
    Acta Trop; 2003 Mar; 85(3):375-90. PubMed ID: 12659975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice.
    Aoki JI; Hong A; Zampieri RA; Floeter-Winter LM; Laranjeira-Silva MF
    J Vis Exp; 2020 Feb; (156):. PubMed ID: 32150165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E; Lang T; Glaichenhaus N; Antoine JC
    J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional paradox in host-pathogen interaction dictates the fate of parasites.
    Dey R; Khan S; Pahari S; Srivastava N; Jadhav M; Saha B
    Future Microbiol; 2007 Aug; 2(4):425-37. PubMed ID: 17683278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell biology of host-parasite membrane interactions in leishmaniasis.
    Chang KP; Fong D
    Ciba Found Symp; 1983; 99():113-37. PubMed ID: 6357669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biogenesis of Leishmania-harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites.
    Courret N; Fréhel C; Gouhier N; Pouchelet M; Prina E; Roux P; Antoine JC
    J Cell Sci; 2002 Jun; 115(Pt 11):2303-16. PubMed ID: 12006615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants and regulation of Leishmania virulence.
    Chang KP; McGwire BS
    Kinetoplastid Biol Dis; 2002 May; 1(1):1. PubMed ID: 12234388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites.
    Sarkar A; Khan YA; Laranjeira-Silva MF; Andrews NW; Mittra B
    J Vis Exp; 2018 Mar; (133):. PubMed ID: 29608175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites.
    Courret N; Prina E; Mougneau E; Saraiva EM; Sacks DL; Glaichenhaus N; Antoine JC
    Eur J Immunol; 1999 Mar; 29(3):762-73. PubMed ID: 10092078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example.
    Bogdan C
    Cell Microbiol; 2008 Jun; 10(6):1221-34. PubMed ID: 18363880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of vaccinal effectiveness of preparations containing membrane antigens of Leishmania (L.) amazonensis in experimental cutaneous leishmaniasis model.
    Ribeiro JG; Ferreira AS; Macedo SRA; Rossi NRDLP; da Silva MCP; Guerra RNM; de Barros NB; Nicolete R
    Int Immunopharmacol; 2017 Jun; 47():227-230. PubMed ID: 28433944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of metacyclic Leishmania promastigotes is associated with the increasing expression of GP65, the major surface antigen.
    Kweider M; Lemesre JL; Santoro F; Kusnierz JP; Sadigursky M; Capron A
    Parasite Immunol; 1989 May; 11(3):197-209. PubMed ID: 2771426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host.
    Naderer T; Vince JE; McConville MJ
    Curr Mol Med; 2004 Sep; 4(6):649-65. PubMed ID: 15357214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages.
    Antoine JC; Prina E; Lang T; Courret N
    Trends Microbiol; 1998 Oct; 6(10):392-401. PubMed ID: 9807783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subversion of host cell signalling by the protozoan parasite Leishmania.
    Gregory DJ; Olivier M
    Parasitology; 2005; 130 Suppl():S27-35. PubMed ID: 16281989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania, macrophages and complement: a tale of subversion and exploitation.
    Mosser DM; Brittingham A
    Parasitology; 1997; 115 Suppl():S9-23. PubMed ID: 9571687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
    Ouaissi A; Ouaissi M
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulator and effector functions of T-cell subsets in human Leishmania infections.
    Kemp M
    APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular growth and pathogenesis of Leishmania parasites.
    Naderer T; McConville MJ
    Essays Biochem; 2011; 51():81-95. PubMed ID: 22023443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells.
    Kima PE; Soong L; Chicharro C; Ruddle NH; McMahon-Pratt D
    Eur J Immunol; 1996 Dec; 26(12):3163-9. PubMed ID: 8977318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.